FDA on Compounded Semaglutide and Teva Pharmacetuical and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance Duvakitug

FDA on the Compounded Semaglutide  The FDA warns that compounded semaglutide is not FDA-approved, meaning it has not been reviewed for safety, effectiveness, or quality. Following the resolution of dr...